CPT3&4 - Clinical Pharmacokinetics & Pharmacodynamics Flashcards
1
Q
5 features of drug bioavailability (F)
Definition/Formula Factors Affecting Bioavailability x5 Plasma Conc-Time Graphs Modified Release Preparation Co-Administration
A
- ) Definition - % of dose of drug that reaches circulation unchanged. It is a measure of drug absorption
- F = [circulation]/dose - ) Factors affecting Bioavailability
- formulation (IV has 100% bioavailability)
- age: luminal changes in intestines
- food: chelation and gastric emptying
- malabsorption: e.g. Crohn’s
- first pass metabolism: gut lumen, gut wall, liver - ) Plasma Conc-Time Graphs - distinct phases
- absorption (increase), distribution (sharp decline) and elimination phase (steady decline) - ) Modified Release Preparation - drug has slower elimination so stays in therapeutic window for longer
- increases adherence as less doses needed
- however, it is a lot more expensive - ) Co-Administration - to increase bioavailability
- e.g anaesthetic + vasoconstrictor (e.g. adrenaline) as reduced blood flow leads to increased absorption
2
Q
4 features of drug distribution
Volume of Distribution
Order of Distribution
Factors Affecting Distribution x4
Multiple Compartment Model
A
- ) Volume of Distribution - how well a drug is distributed out of blood plasma (circulation)
- Vd = dose/[drug in plasma], L/kg
- the larger the weight, the larger the Vd because the molecule can distribute even further so less in plasma - ) Order of Distribution
- plasma –> interstitium –> cells –> tissues (fat)
- Vd of around 5L suggests mosts of the drug stays in circulation (blood volume is roughly 5L)
3.) Factors affecting Distribution - blood flow, capillary structure, lipophilicity, protein binding
- ) Multiple Compartment Model - rate of distribution and equilibration from IV follows this model
- the more compartments, the slower the distribution
3
Q
3 features of drug metabolism
Cytochrome P450 Enzymes
Effect on Drugs x3
Factors Affecting Metabolism x9
A
- ) Cytochrome P450 Enzymes - phase I metabolism (OILRIG)
- converts drugs into lipophilic metabolites
- can be induced or inhibited by other compounds e.g. grapefruit juice inhibits CYPs that metabolises statins - ) Effect on Drugs
- active –> inactive: most drugs
- inactive –> active: e.g. ACEi, aspirin (prodrugs)
- active –> active: e.g. codeine –> morphine - ) Factors Affecting Metabolism
- size, lipophilicity, hydrophilicity, structural complexity
- age, liver failure, blood flow, alcohol, smoking
4
Q
3 routes of drug elimination
Renal
Hepatic
Other Routes x3
A
- ) Renal Elimination - main route of elimination
- mainly remove low molecular weight polar metabolites
- affected by: GFR, pH, lipophilicity, protein binding, competition for transporters - ) Hepatic Elimination - removes high molecular weight metabolites conjugated w/ glucuronic acid
- uses enterohepatic circulation to eliminate in faeces or reabsorption - ) Other Routes - fluids, solids, gases
- fluids: sweat, tears, saliva, lactation, genital secretions
- solids: faeces, hair
- gases: volatile compounds
5
Q
4 features of elimination rate and clearance
Order Kinetics
Clearance
Half-Life Equation
Amiodarone Elimination
A
- ) Order Kinetics - 0 order= linear, 1st = exponential
- half-life used for 1st order kinetics
- most drugs exhibit 1st order at therapeutic doses
- high doses, alcohol, salicylic acid and phenytoin are all zero order so half-life not calculable - ) Clearance - volume of blood cleared per unit time
- CL = elimination rate/[drug in plasma], ml/min
- elimination rate = [drug]/time, mg/min - ) Half-Life Equation - t1/2 = 0.693 x (Vd/CL)
- higher Vd = longer half-life = worse elimination - ) Amiodarone Elimination - used to treat SVTs
- very high Vd (66L/kg) so long half-life (50-60days) so takes a very long time to eliminate
- can increase [plasma] of other cardiac drugs
- can easily lead to medication errors
6
Q
5 features of steady state concentration (Css)
Definition Reaching Css Css Equation Oral Administration Rate Loading Dose
A
- ) Definition - stable concentration the drug reaches after giving repeated doses of the drug
- therapeutic benefit optimal at steady state - ) Reaching Css - takes 5 half-lives
- also takes 5 half-lives to eliminate the drug from Css
- at steady state, rate of infusion = rate of elimination - ) Css Equation
- CL = infusion rate(elimination rate)/Css([drug])
- therefore: Css = infusion rate/CL - ) Oral Administration Rate = (D/t) x F (amount/time x bioavailability), oral equivalent of infusion rate
- at steady state, administration rate = elimination rate
- (DxF)/t = CL x Css, therefore, Css = (DxF)/(txCL)
- D is the maintenance dose and t is the interval between doses - ) Loading Dose - single dose to achieve desired conc in apparent volume of distribution, Vd
- Dose = Vd x [drug in plasma]
- Loading Dose = Vd x Css
7
Q
8 Important Equations
Bioavailability Volume of Distribution Clearance Half-Life IV Css Oral Css Loading Dose Therapeutic Index
A
- ) Bioavailability (%) = [circulation]/dose,
- ) Volume of Distribution (L/kg) = dose/[drug in plasma]
- ) Clearance (ml/min) - elimination rate/[drug in plasma]
- ) Half-Life (hours) - 0.693 x (Vd/CL)
- ) IV Css (mg/L) - infusion rate/CL
- ) Oral Css (mg/L) - (DxF)/(txCL)
- Css is increased by increasing the maintenance dose or decreasing the time interval
7.) Loading Dose (mg/kg) - Vd x Css
- ) Therapeutic Index - ratio
- max therapeutic dose/minimum therapeutic dose